Do rheumatoid arthritis patients in clinical practice benefit from switching from infliximab to a second tumor necrosis factor alpha inhibitor?
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Merete Lund Hetland Hanne Lindegaard |
| Publication date | March 27, 2007 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |